Supplementary Figure 12 from AMT-562, a Novel HER3-targeting Antibody–Drug Conjugate, Demonstrates a Potential to Broaden Therapeutic Opportunities for HER3-expressing Tumors
openalex（2023）
摘要
AMT-562 is more effective as single agent or in combination therapy for colorectal cancer.
查看译文
关键词
antibody–drug conjugate,tumors
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要